Increased prevalence of comorbid conditions in women with uterine cancer

• Uterine cancer patients have significantly higher odds of multiple comorbidities.
• Increased odds of the most common comorbidities persisted after age adjustment.
• Survivorship programs should target components of the metabolic syndrome.

ObjectivesTo compare comorbidities of women with uterine cancer (UC) to controls so as to aid in development of survivorship care plans and programs.MethodsRetrospective cohort study using the University HealthSystem Consortium (UHC) database that compared women who had a hysterectomy for UC to women without UC undergoing hysterectomy. Frequencies and odds ratios (ORs) of 26 comorbidities were calculated. Mantel–Haenszel stratified ORs were determined to correct for different age distributions between the UC and control groups using UHC predetermined age groups.Results23,227 patients in the dataset were included in the UC cohort, and 142,601 patients served as controls. Uncorrected ORs ≥ 2 were found for hypertension, diabetes, obesity, congestive heart failure, pulmonary circulatory diseases, peripheral vascular disease, and renal failure. Higher ORs for UC remained significant after stratification by age for hypertension (OR = 1.7), diabetes (OR = 2.1), obesity (OR = 3.3), congestive heart failure (OR = 1.5), pulmonary circulatory disorders (OR = 1.7), and renal failure (OR = 1.2).ConclusionsMultiple comorbid conditions, specifically those related to the metabolic syndrome, were more prevalent in UC survivors than in the general population, and this difference persisted after adjustment for age. UC survivorship programs should plan to allocate resources to account for these differences in healthcare needs.